Expression of beta-catenin by acute myeloid leukemia cells predicts enhanced clonogenic capacities and poor prognosis (Q40281355)

19 September 2017

title

Expression of beta-catenin by acute myeloid leukemia cells predicts enhanced clonogenic capacities and poor prognosis (English)

1 reference

19 September 2017

1 reference

acute myeloid leukemia

1 reference

Ysebaert L

1 reference

19 September 2017

Chicanne G

1 reference

19 September 2017

Demur C

1 reference

19 September 2017

De Toni F

1 reference

19 September 2017

Prade-Houdellier N

1 reference

19 September 2017

Ruidavets JB

1 reference

19 September 2017

Mansat-De Mas V

1 reference

19 September 2017

Rigal-Huguet F

1 reference

19 September 2017

Laurent G

1 reference

19 September 2017

Payrastre B

1 reference

19 September 2017

Manenti S

1 reference

19 September 2017

Racaud-Sultan C

1 reference

19 September 2017

publication date

11 May 2006

1 reference

19 September 2017

1 reference

19 September 2017

1 reference

19 September 2017

1 reference

19 September 2017

page(s)

1211-1216

1 reference

Applying the principles of stem-cell biology to cancer

19 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404239

Stem cells, cancer, and cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404239

You Wnt some, you lose some: oncogenes in the Wnt signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404239

A role for Wnt signalling in self-renewal of haematopoietic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404239

Wnt proteins are lipid-modified and can act as stem cell growth factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404239

WNT signalling and haematopoiesis: a WNT-WNT situation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404239

Activation of the Wnt signaling pathway in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404239

Wnt signaling in B-cell neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404239

Illegitimate WNT signaling promotes proliferation of multiple myeloma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404239

Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404239

Translocation products in acute myeloid leukemia activate the Wnt signaling pathway in hematopoietic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404239

Gamma-catenin contributes to leukemogenesis induced by AML-associated translocation products by increasing the self-renewal of very primitive progenitor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404239

Oncogenic homeodomain transcription factor E2A-Pbx1 activates a novel WNT gene in pre-B acute lymphoblastoid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404239

Regulation of leukemic cell adhesion, proliferation, and survival by beta-catenin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404239

Constitutive activation of the Wnt/beta-catenin signalling pathway in acute myeloid leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404239

Flt3 tandem duplication mutations cooperate with Wnt signaling in leukemic signal transduction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404239

Autonomous proliferation of leukemic cells in vitro as a determinant of prognosis in adult acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404239

Aberrant expression of beta-catenin discriminates acute myeloid leukaemia from acute lymphoblastic leukaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404239

An autocrine mechanism for constitutive Wnt pathway activation in human cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404239

Wnt signaling regulates hemopoiesis through stromal cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404239

Small-molecule antagonists of the oncogenic Tcf/beta-catenin protein complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404239

RELATION OF BLAST CELL SURVIVAL AND PROLIFERATION TO CHEMOTHERAPY RESISTANCE IN AML

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404239

In vitro growth in acute myeloblastic leukaemia: relationship with other clinico-biological characteristics of the disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404239

7 January 2021

Acute myeloid leukemia cells with low P-glycoprotein expression and high rhodamine 123 efflux capacity display high clonogenicity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404239

7 January 2021

Wnt5a inhibits B cell proliferation and functions as a tumor suppressor in hematopoietic tissue

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404239

7 January 2021

Cytogenetic risk groups in acute myeloblastic leukaemia differ greatly in their semi-solid colony growth

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404239

7 January 2021

Identifiers

DOI

10.1038/SJ.LEU.2404239

1 reference

Dimensions Publication ID

19 September 2017

1001998743

0 references

1 reference